Jiangsu Lanfeng Bio-Chemical announced that the company's controlling subsidiary Xuhe Technology intends to introduce investor Chang'an Trust for capital increase, with an amount of 98.01 million yuan, of which 17.82 million yuan is credited to registered capital and 80.19 million yuan is credited to capital reserves. The company and other existing shareholders of Xuhe Technology have waived their preferential subscription rights for the above capital increase. After this capital increase is completed, the company's shareholding ratio in Xuhe Technology will change from 51% to 49.2449%, and Xuhe Technology will still be the company's controlling subsidiary.